- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 311/76 - Benzo [c] pyrannes
Détention brevets de la classe C07D 311/76
Brevets de cette classe: 138
Historique des publications depuis 10 ans
|
10
|
12
|
12
|
17
|
10
|
4
|
7
|
11
|
11
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Bristol-myers Squibb Company | 4892 |
10 |
| Autifony Therapeutics Limited | 48 |
7 |
| Sunovion Pharmaceuticals Inc. | 271 |
6 |
| PGI Drug Discovery LLC | 30 |
5 |
| Sumitomo Pharma America, Inc. | 52 |
5 |
| Biogen MA Inc. | 892 |
3 |
| Orion Corporation | 609 |
3 |
| Zhejiang Ausun Pharmaceutical Co., Ltd. | 35 |
3 |
| USA Elixiria Biotech Inc | 3 |
3 |
| International Business Machines Corporation | 61023 |
2 |
| Mayo Foundation for Medical Education and Research | 3188 |
2 |
| Beijing Shenogen Pharma Group Ltd. | 21 |
2 |
| BioMarin Pharmaceutical Inc. | 378 |
2 |
| The Hospital for Sick Children | 407 |
2 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 163 |
2 |
| Invizyne Technologies, Inc. | 16 |
2 |
| Inventisbio LLC | 27 |
2 |
| Inventisbio Co., Ltd. | 67 |
2 |
| Alonbio Ltd. | 12 |
2 |
| Lario Therapeutics Ltd | 12 |
2 |
| Autres propriétaires | 71 |